Results 31 to 40 of about 1,464 (122)

Comparative Study of Influenza Virus and Parainfluenza 3 Virus as Causative Agents of Upper Respiratory System in Thi-Qar Province

مجلة علوم ذي قار, 2022
The current study is targeted for detection of the some important respiratory pathogen viruses which responsible for respiratory tract infections, Influenza A virus (IAV) and human Parainfluenza viruses (HPIVs) are considered of the causes of ...
Abeer Al Ghazi, Basim Al Ghazi
doaj   +1 more source

Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3.

PLoS Pathogens, 2022
We previously found that, among human parainfluenza virus type 3 (HPIV3) proteins, the interaction of nucleoprotein (N) and phosphoprotein (P) provides the minimal requirement for the formation of cytoplasmic inclusion bodies (IBs), which are sites of ...
Pengfei Liu, Shengwei Zhang, Jingyi Ma, Dongning Jin, Yali Qin, Mingzhou Chen   +5 more
doaj   +1 more source

Wheat germ cell-free system-based production of hemagglutinin-neuraminidase protein of human parainfluenza virus type 3: generation and characterization of monoclonal antibody

Frontiers in Microbiology, 2014
Human parainfluenza virus 3 (HPIV3) commonly causes respiratory disorders in infants and young children. Monoclonal antibodies (MAbs) have been produced to several components of HPIV3 and commercially available.
Satoko eMatsunaga, Shiho eKawakami, Akiko eOkayama, Hiroyuki eTsukagoshi, Ayumi eKudoh, Izumi eMatsuo, Yuki eMatsushima, Hideaki eShimizu, Nobuhiko eOkabe, Hisashi eHirano, Naoki eYamamoto, Hirokazu eKimura, Akihide eRyo   +12 more
doaj   +1 more source

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1

Frontiers in Immunology, 2020
Human Parainfluenza Virus-3 (HPIV3) causes severe respiratory illness in immunocompromised patients and lacks approved anti-viral therapies. A phase I study of adoptively transferred virus-specific T-cells (VSTs) targeting HPIV3 following bone marrow ...
Katherine M. Harris, Katherine M. Harris, Sarah E. Horn, Melanie L. Grant, Haili Lang, Gelina Sani, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Anushree Datar, Christopher A. Lazarski, Catherine M. Bollard, Catherine M. Bollard, Catherine M. Bollard, Michael D. Keller, Michael D. Keller, Michael D. Keller   +15 more
doaj   +1 more source

Involvement of Actin-Regulating Factor Cofilin in the Inclusion Body Formation and RNA Synthesis of Human Parainfluenza Virus Type 3 via Interaction With the Nucleoprotein

Frontiers in Microbiology, 2019
Human parainfluenza virus type 3 (HPIV3) is one of the primary pathogens that causing severe respiratory tract diseases in newborns and infants. It could induce inclusion bodies (IBs) in infected cells.
Yinshuang Li, Yinshuang Li, Chaoliang Zhang, Chaoliang Zhang, Nan Lu, Xichuan Deng, Guangchao Zang, Shengwei Zhang, Hong Tang, Guangyuan Zhang   +9 more
doaj   +1 more source

Multipotent Antiviral Effects of Deacetylated Chitosan Supplemented with Grapefruit Seed Extract against Influenza and Parainfluenza Viruses

Applied Sciences, 2023
Chitosan, poly[β-(1–4)-linked-2-amino-2-deoxy-d-glucose], is a polysaccharide with broad applications in various biomaterial and biomedical fields, primarily because of its nontoxicity.
Dong Soo Seo, Joong Su Lee, Yong Chul Shin, Younghoon Jang   +3 more
doaj   +1 more source

Human Parainfluenza Virus Type 3 in Wild Nonhuman Primates, Zambia

Emerging Infectious Diseases, 2013
Human parainfluenza virus type 3 (HPIV3) genome was detected in 4 baboons in Zambia. Antibody for HPIV3 was detected in 13 baboons and 6 vervet monkeys in 2 distinct areas in Zambia.
Michihito Sasaki, Akihiro Ishii, Yasuko Orba, Yuka Thomas, Bernard M. Hang’ombe, Ladslav Moonga, Aaron S. Mweene, Hirohito Ogawa, Ichiro Nakamura, Takashi Kimura, Hirofumi Sawa   +10 more
doaj   +1 more source

Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. [PDF]

PLoS ONE, 2010
Human respiratory syncytial virus (HRSV), and to a lesser extent human metapneumovirus (HMPV) and human parainfluenza virus type 3 (HPIV3), re-infect symptomatically throughout life without antigenic change, suggestive of incomplete immunity.
Cyril Le Nouën, Philippa Hillyer, Shirin Munir, Christine C Winter, Thomas McCarty, Alexander Bukreyev, Peter L Collins, Ronald L Rabin, Ursula J Buchholz   +8 more
doaj   +1 more source

Evaluation of the Level of CXCL10 in Patients with Parainfluenza Virus Type III (HPIV3)

Medico-Legal Update, 2020
Acute respiratory illness could be caused by Human parainfluenza viruses (PIVs) in children, the old, and immunocompromised patients. The frequent and common cause of pneumonia and bronchiolitis is PIV3, whilst the upper respiratory tract illness and croup are frequently caused by PIV1 and PIV2.
openaire   +2 more sources

Effect of ultrasound with methylene blue as sound sensitive agent on virus inactivation

Medicine in Novel Technology and Devices, 2023
The goal of this paper is to explore a method for virus inactivation based on ultrasonic treatment, and on this basis, to explore the synergistic effect of methylene blue as a sonosensitizer in virus inactivation.
Nan Lu, Yunbo Tian, Lan Wei, Guangyuan Zhang, Chengbing Xie, Tao He, Yongzhu Xu, Ziqiu Hu, Guixue Wang   +8 more
doaj   +1 more source